Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial

Míreanna comhchosúla

• Thromboxane biosynthesis and future events in diabetes: the ASCEND trial
  de réir: Petrucci, G, et al.
  Foilsithe / Cruthaithe: (2024)
• Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
  de réir: Parish, S, et al.
  Foilsithe / Cruthaithe: (2023)
• Once daily low-dose aspirin reduces urinary thromboxane B2 effectively even at 12-24 hours from dosing in the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial
  de réir: Aung, T, et al.
  Foilsithe / Cruthaithe: (2017)
• Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
  de réir: Sarah Parish, et al.
  Foilsithe / Cruthaithe: (2023-03-01)
• Measurement of Thromboxane Biosynthesis in Health and Disease
  de réir: Carlo Patrono, et al.
  Foilsithe / Cruthaithe: (2019-10-01)